<DOC>
	<DOCNO>NCT02847052</DOCNO>
	<brief_summary>IL-22 IL-10 family cytokine play major action increase intestinal epithelial barrier function regeneration experimental colitis . IL-22 binding protein small , soluble , secrete protein potently inhibit IL-22 action prevent bind IL-22 Recepteur . This study aim characterize IL-22 binding protein regulate Inflammatory bowel disease well understand way IL-22 act epithelial cell flare disease .</brief_summary>
	<brief_title>Study Role Soluble Inhibitor Interleukin 22 , Interleukin 22 Binding Protein ( IL-22BP ) , Chronic Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Inclusion criterion 1 . Crohn 's disease Ulcerative colitis 2 . Healthy control paired age sex 3 . Samples availability biobank 4 . Signed consent 5 . No ( Immune Mediated Inflammatory Disorders Inflammatory bowel disease 6 . No condition predict know affect IL22/IL22 recepteur /IL22 bind protein regulation 7 . Availability clinical data 8 . Age &gt; 18 y.o . 9 . No pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>